Print ResearchMayo Clinic researchers are studying the use of COVID-19 convalescent plasma therapy. They are focusing on people in the hospital for COVID-19 and people with severely weakened immune systems who have COVID-19. The goal is to determine if COVID-19 convalescent plasma therapy improves the chance of recovery for people with the most severe disease. They also plan to test whether COVID-19 convalescent plasma can help keep people who are moderately sick from getting sicker. And they will test COVID-19 convalescent plasma to see if it helps prevent the need for hospitalization. Find out more about researchCOVID-19 at Mayo Clinic. PublicationsSee a list of publications about convalescent plasma therapy by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine. Research Profiles Edit search filters close Narrow your search By location Arizona Florida Minnesota View all View all physicians • Arizona By Mayo Clinic Staff Convalescent plasma therapy care at Mayo Clinic AboutCare at Mayo Clinic July 21, 2023 Print Show references Investigational COVID-19 convalescent plasma. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/investigational-covid-19-convalescent-plasma. Accessed May 2, 2023. Hoffman R, et al. Principles of plasma and plasma derivatives. In: Hematology. 8th edition. Elsevier. 2023. https://www.clinicalkey.com. Accessed May 2, 2023. Marano G, et al. Convalescent plasma: New evidence for an old therapeutic tool? Blood Transfusion. 2016; doi:10.2450/2015.0131-15. Emergency use authorization. U.S. Food and Drug Administration. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization. Accessed May 2, 2023. AskMayoExpert. Convalescent Plasma. Mayo Clinic; 2023. COVID-19 convalescent plasma. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/covid-19-convalescent-plasma/. Accessed May 2. 2023. Rajendran K, et al. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. Journal of Medical Virology. 2020; doi:10.1002/jmv.25961. Senefeld JW, et al. COVID-19 Convalescent plasma for the treatment of immunocompromised patients: A systematic review and meta-analysis. Journal of the American Medical Association: Network Open. 2023; doi:10.1001/jamanetworkopen.2022.50647. COVID-19 treatments and medications. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html. Accessed May 2, 2023. Kim AR. Coronavirus disease 2019 (COVID-19): Management in hospitalized adults. https://www.uptodate.com/contents/search. Accessed May 2, 2023. Infectious disease, HLA and ABO donor qualification testing. American Red Cross. https://www.redcrossblood.org/biomedical-services/blood-diagnostic-testing/blood-testing.html. Accessed May 3, 2023. Tulledge-Scheitel, S (expert opinion). Mayo Clinic. May 5, 2023. Related Coronavirus disease 2019 (COVID-19) Products & Services A Book: Endemic - A Post-Pandemic Playbook Convalescent plasma therapyAboutDoctors&DepartmentsCare atMayoClinic PRC-20486437 Patient Care & Health Information Tests & Procedures Convalescent plasma therapy